The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
The application of in silico drug-likeness predictions in pharmaceutical research
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cortes, C., & Vapnik, V. (1995) · Machine Learning · doi:10.1007/bf00994018 · Cited by 59,421
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,199
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
Ghose, A. K., Viswanadhan, V. N., & Wendoloski, J. J. (1999) · Journal of Combinatorial Chemistry · doi:10.1021/cc9800071 · Cited by 3,068
The Properties of Known Drugs. 1. Molecular Frameworks
Bemis, G. W., & Murcko, M. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9602928 · Cited by 2,482
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Quantifying the chemical beauty of drugs
Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,242
DrugBank 4.0: shedding new light on drug metabolism
Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1068 · Cited by 1,993
The Many Roles of Computation in Drug Discovery
Jorgensen, W. L. (2004) · Science · doi:10.1126/science.1096361 · Cited by 1,554
Simple Selection Criteria for Drug-like Chemical Matter
Muegge, I., Heald, S. L., & Brittelli, D. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm015507e · Cited by 1,315
Hit and lead generation: beyond high-throughput screening
Bleicher, K. H., Böhm, H.-J., Müller, K., & Alanine, A. I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1086 · Cited by 1,056
Dobson, C. M. (2004) · Nature · doi:10.1038/nature03192 · Cited by 1,003
Navigating chemical space for biology and medicine
Lipinski, C., & Hopkins, A. (2004) · Nature · doi:10.1038/nature03193 · Cited by 1,002
Walters, W. P., Stahl, M. T., & Murcko, M. A. (1998) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01163-x · Cited by 991
Feher, M., & Schmidt, J. M. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0200467 · Cited by 927
Lewell, X. Q., Judd, D. B., Watson, S. P., & Hann, M. M. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci970429i · Cited by 691
Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and Trials
Corson, T. W., & Crews, C. M. (2007) · Cell · doi:10.1016/j.cell.2007.08.021 · Cited by 654
Property distribution of drug-related chemical databases*
Oprea, T. I. (2000) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008130001697 · Cited by 628
The influence of lead discovery strategies on the properties of drug candidates
Keserü, G. M., & Makara, G. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2796 · Cited by 628
The New Face of Traditional Chinese Medicine
Normile, D. (2003) · Science · doi:10.1126/science.299.5604.188 · Cited by 603
Computational methods for the prediction of ‘drug-likeness’
Clark, D. E., & Pickett, S. D. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01451-8 · Cited by 578
Byvatov, E., Fechner, U., Sadowski, J., & Schneider, G. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0341161 · Cited by 565
A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs
Wenlock, M. C., Austin, R. P., Barton, P., Davis, A. M., & Leeson, P. D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021053p · Cited by 546
Pursuing the leadlikeness concept in pharmaceutical research
Hann, M. M., & Oprea, T. I. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.003 · Cited by 515
Can We Learn To Distinguish between “Drug-like” and “Nondrug-like” Molecules?
Ajay, Walters, W. P., & Murcko, M. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970666c · Cited by 484
Ghose, A. K., Herbertz, T., Hudkins, R. L., Dorsey, B. D., & Mallamo, J. P. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200100h · Cited by 447
Walters, W. P., & Murcko, M. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00003-0 · Cited by 439
Selection criteria for drug‐like compounds
Muegge, I. (2003) · Medicinal Research Reviews · doi:10.1002/med.10041 · Cited by 412
A Scoring Scheme for Discriminating between Drugs and Nondrugs
Sadowski, J., & Kubinyi, H. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9706776 · Cited by 392
Designing screens: how to make your hits a hit
Walters, W. P., & Namchuk, M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1063 · Cited by 374
Drug research: myths, hype and reality
Kubinyi, H. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1156 · Cited by 348
The Role of Absorption, Distribution, Metabolism, Excretion and Toxicity in Drug Discovery
Lin, J., Sahakian, D., de Morais, S., Xu, J., Polzer, R., & Winter, S. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452096 · Cited by 327
Designing Libraries with CNS Activity
Ajay, Bemis, G. W., & Murcko, M. A. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990017w · Cited by 316
Going further than Lipinski's rule in drug design
Walters, W. P. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.648612 · Cited by 306
Natural-product-derived fragments for fragment-based ligand discovery
Over, B., Wetzel, S., Grütter, C., Nakai, Y., Renner, S., Rauh, D., & Waldmann, H. (2013) · Nature Chemistry · doi:10.1038/nchem.1506 · Cited by 300
Lee, M.-L., & Schneider, G. (2001) · Journal of Combinatorial Chemistry · doi:10.1021/cc000097l · Cited by 293
Pharmaceutical profiling in drug discovery
Kerns, E. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02649-7 · Cited by 288
Assessing drug-likeness – what are we missing?
Vistoli, G., Pedretti, A., & Testa, B. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.007 · Cited by 278
Ursu, O., Rayan, A., Goldblum, A., & Oprea, T. I. (2011) · WIREs Computational Molecular Science · doi:10.1002/wcms.52 · Cited by 276
Properties of Known Drugs. 2. Side Chains
Bemis, G. W., & Murcko, M. A. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9903996 · Cited by 271
Hou, T., Wang, J., Zhang, W., & Xu, X. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600343x · Cited by 228
Self-citationThe Rule of Five Revisited: Applying Log D in Place of Log P in Drug-Likeness Filters
Bhal, S. K., Kassam, K., Peirson, I. G., & Pearl, G. M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp0700209 · Cited by 220
Scaffold diversity of natural products: inspiration for combinatorial library design
Grabowski, K., Baringhaus, K.-H., & Schneider, G. (2008) · Natural Product Reports · doi:10.1039/b715668p · Cited by 218
Zernov, V. V., Balakin, K. V., Ivaschenko, A. A., Savchuk, N. P., & Pletnev, I. V. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0340916 · Cited by 209
Recent Development and Application of Virtual Screening in Drug Discovery: An Overview
Hou, T., & Xu, X. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043452721 · Cited by 189
Self-citationHou, T., Wang, J., Zhang, W., & Xu, X. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci6003515 · Cited by 178
Self-citationIdentification of Biological Activity Profiles Using Substructural Analysis and Genetic Algorithms
Gillet, V. J., Willett, P., & Bradshaw, J. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci970431+ · Cited by 176
Recent Advances in Computational Prediction of Drug Absorption and Permeability in Drug Discovery
Hou, T., Wang, J., Zhang, W., et al. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706778201558 · Cited by 169
Self-citationImproving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits
Wunberg, T., Hendrix, M., Hillisch, A., Lobell, M., Meier, H., Schmeck, C., Wild, H., & Hinzen, B. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03700-1 · Cited by 152
Combinatorial Library Design Using a Multiobjective Genetic Algorithm
Gillet, V. J., Khatib, W., Willett, P., Fleming, P. J., & Green, D. V. S. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010375j · Cited by 149
Potential Drugs and Nondrugs: Prediction and Identification of Important Structural Features
Wagener, M., & van Geerestein, V. J. (2000) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci990266t · Cited by 138
Considering the impact drug-like properties have on the chance of success
Yusof, I., & Segall, M. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.02.008 · Cited by 137
Improving the Odds in Discriminating “Drug-like” from “Non Drug-like” Compounds
Frimurer, T. M., Bywater, R. P., Nærum, L., Nørskov‐Lauritsen, L., & Brunak, S. (2000) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0003810 · Cited by 129
The evolution of synthetic oral drug properties
Proudfoot, J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.12.024 · Cited by 129
Selecting Combinatorial Libraries to Optimize Diversity and Physical Properties
Gillet, V. J., Willett, P., Bradshaw, J., & Green, D. V. S. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci980332b · Cited by 127
Descriptors, Physical Properties, and Drug-Likeness
Brüstle, M., Beck, B., Schindler, T., King, W., Mitchell, T. J., & Clark, T. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm011027b · Cited by 121
Tian, S., Wang, J., Li, Y., Xu, X., & Hou, T. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300198d · Cited by 118
Self-citationDrug and Drug Candidate Building Block Analysis
Wang, J., & Hou, T. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900398f · Cited by 116
Self-citationDependence of Molecular Properties on Proteomic Family for Marketed Oral Drugs
Vieth, M., & Sutherland, J. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0603825 · Cited by 103
Molecular properties that influence oral drug-like behavior.
Lajiness, M. S., Vieth, M., & Erickson, J. A. (2004) · PubMed · Cited by 102
Towards a new age of virtual ADME/TOX and multidimensional drug discovery
Ekins, S., Boulanger, B., Swaan, P. W., & Hupcey, M. A. Z. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1020816005910 · Cited by 101
Takaoka, Y., Endo, Y., Yamanobe, S., Kakinuma, H., Okubo, T., Shimazaki, Y., Ota, T., Sumiya, S., & Yoshikawa, K. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034043l · Cited by 97
How drug-like are ‘ugly’ drugs: do drug-likeness metrics predict ADME behaviour in humans?
Ritchie, T. J., & Macdonald, S. J. F. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.01.007 · Cited by 88
Classifying ‘Drug-likeness' with Kernel-Based Learning Methods
Müller, K., Rätsch, G., Sonnenburg, S., Mika, S., Grimm, M., & Heinrich, N. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049737o · Cited by 85
Shen, M., Tian, S., Li, Y., Li, Q., Xu, X., Wang, J., & Hou, T. (2012) · Journal of Cheminformatics · doi:10.1186/1758-2946-4-31 · Cited by 83
Self-citationDrugs in other drugs: a new look at drugs as fragments
Siegel, M. G., & Vieth, M. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.011 · Cited by 79
A New Rapid and Effective Chemistry Space Filter in Recognizing a Druglike Database
Zheng, S., Luo, X., Chen, G., Zhu, W., Shen, J., Chen, K., & Jiang, H. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci050031j · Cited by 74
Chemical Fragments as Foundations for Understanding Target Space and Activity Prediction
Sutherland, J. J., Higgs, R. E., Watson, I., & Vieth, M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701399f · Cited by 68
Gradual in Silico Filtering for Druglike Substances
Schneider, N., Jäckels, C., Andrés, C., & Hutter, M. C. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci700351y · Cited by 61
Guiding molecules towards drug-likeness.
Egan, W. J., Walters, W. P., & Murcko, M. A. (2002) · PubMed · Cited by 56
Wang, J., & Ramnarayan, K. (1999) · Journal of Combinatorial Chemistry · doi:10.1021/cc990032m · Cited by 55
Self-citationZuegg, J., & Cooper, M. A. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612802652466 · Cited by 52
Li, Q., Bender, A., Pei, J., & Lai, L. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700107y · Cited by 49
Drug Development and FDA Approval, 1938–2013
Darrow, J. J., & Kesselheim, A. S. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1402114 · Cited by 47
Good, A. C., & Hermsmeier, M. A. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci6003493 · Cited by 26
Design strategies for building drug-like chemical libraries.
Mitchell, T. J., & Showell, G. A. (2001) · PubMed · Cited by 21
Yin and Yang in Medicinal Chemistry: What Does Drug-Likeness Mean?
Macarrón, R., & Luengo, J. I. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.19 · Cited by 16
Optimization of the drug-likeness of chemical libraries
Sadowski, J. (2000) · Perspectives in Drug Discovery and Design · doi:10.1023/a:1008756317345 · Cited by 10
Optimization of the drug-likeness of chemical libraries
Sadowski, J. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46883-2_2 · Cited by 6
(1999) · doi:10.1002/(sici)1521-3773(19990301)38:5<643::aid-anie643>3.0.co;2-g
Cited by
Daina, A., Michielin, O., & Zoete, V. (2017) · Scientific Reports · doi:10.1038/srep42717 · Cited by 18,367
A BOILED‐Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules
Daina, A., & Zoete, V. (2016) · ChemMedChem · doi:10.1002/cmdc.201600182 · Cited by 2,549
ADMET-score – a comprehensive scoring function for evaluation of chemical drug-likeness
Guan, L., Yang, H., Cai, Y., Sun, L., Di, P., Li, W., Liu, G., & Tang, Y. (2019) · MedChemComm · doi:10.1039/c8md00472b · Cited by 712
A drug-likeness toolbox facilitates ADMET study in drug discovery
Jia, C.-Y., Li, J.-Y., Hao, G.-F., & Yang, G.-F. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2019.10.014 · Cited by 547
A review on machine learning approaches and trends in drug discovery
Carracedo-Reboredo, P., Liñares-Blanco, J., Rodríguez-Fernández, N., Cedrón, F., Novoa, F. J., Carballal, A., Maojo, V., Pazos, A., & Fernandez-Lozano, C. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.08.011 · Cited by 472
Metadata
- Authors
- Tian, S., Wang, J., Li, Y., Li, D., Xu, L., & Hou, T.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 86
- Pages
- 2-10
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1987612487
- Cited by
- 498
- References
- 85
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.